| Deferiprone treatment in aged transgenic tau mice improves Y-maze performance and alters tau pathology SS Rao, L Lago, I Volitakis, JJ Shukla, G McColl, DI Finkelstein, PA Adlard Neurotherapeutics 18 (2), 1081-1094, 2021 | 20 | 2021 |
| Therapeutic potential of iron modulating drugs in a mouse model of multiple system atrophy JJ Shukla, N Stefanova, AI Bush, G McColl, DI Finkelstein, EJ McAllum Neurobiology of Disease 159, 105509, 2021 | 13 | 2021 |
| The compound ATH434 prevents alpha-synuclein toxicity in a murine model of multiple system atrophy DI Finkelstein, JJ Shukla, RA Cherny, JL Billings, E Saleh, N Stefanova, ... Journal of Parkinson's Disease 12 (1), 105-115, 2022 | 11 | 2022 |
| Retraction Note: Deferiprone Treatment in Aged Transgenic Tau Mice Improves Y-Maze Performance and Alters Tau Pathology SS Rao, L Lago, I Volitakis, JJ Shukla, G McColl, DI Finkelstein, PA Adlard Neurotherapeutics 20 (6), 1894, 2023 | | 2023 |
| Deferiprone Treatment in Aged Transgenic Tau Mice Improves Y-Maze Performance and Alters Tau Pathology (vol 18, pg 1081, 2021) SS Rao, L Lago, I Volitakis, JJ Shukla, G McColl, DI Finkelstein, PA Adlard NEUROTHERAPEUTICS 18 (4), 2759-2761, 2021 | | 2021 |
